Total Synthesis and Antitumor Activity of ZK-EPO: The First Fully Synthetic Epothilone in Clinical Development
โ Scribed by Ulrich Klar; Bernd Buchmann; Wolfgang Schwede; Werner Skuballa; Jens Hoffmann; Rosemarie B. Lichtner
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 601 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0044-8249
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The clinical success of paclitaxel (PT) in the treatment of ovarian and breast cancer strongly contributed to the assessment that tubulin is one of the best clinically validated targets in tumor therapy. However, one disadvantage with PT and other taxane analogues is their recognition by cellular ef
**__Nature is a brilliant architect__** for the design of compounds with interesting biological functions. Epothilone B (top), a metabolite of myxobacteria (fruiting body in background), served as the lead structure for the development of an anticancer drug candidate. Optimization efforts led to ZKโ